Asunaprevir
id:
asunaprevir-260-782305
title:
Asunaprevir
text:
Asunaprevir is an experimental drug candidate for the treatment of hepatitis C. It was undergoing development by Bristol-Myers Squibb and has completed Phase III clinical trials in 2013. Asunaprevir is an inhibitor of the hepatitis C virus enzyme serine protease NS3. Asunaprevir is being tested in combination with pegylated interferon and ribavirin, as well as in interferon-free regimens with other direct-acting antiviral agents including daclatasvir.
brand slug:
wiki
category slug:
encyclopedia
description:
Compound
original url:
https://en.wikipedia.org/wiki/Asunaprevir
date created:
date modified:
2024-04-07T05:20:03Z
main entity:
{"identifier":"Q4811881","url":"https://www.wikidata.org/entity/Q4811881"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/8/87/Asunaprevir.svg","width":512,"height":463}
fields total:
13
integrity:
15